Need Help?

Gene signature for predicting homologous recombination deficiency in triple-negative breast cancer

We developed a gene expression-based classifier for homologous recombination deficiency (HRD) in breast cancer patients using WES and RNA-seq data obtained from 94 TNBC samples from a Malaysian hospital-based cohort (MyBrCa). This classifier was able to predict for high levels of a mutational signature associated with HRD in an additional MyBrCa TNBC validation cohort (this EGA study) as well as in TNBCs from TCGA. We also validated the classifier on a NanoString platform with both fresh frozen and FFPE tissue.

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID Description Technology Samples
EGAD00001009311 Illumina NovaSeq 6000 105
Publications Citations
Clustering of HR + /HER2- breast cancer in an Asian cohort is driven by immune phenotypes.
Breast Cancer Res 26: 2024 67
0
Gene expression signature for predicting homologous recombination deficiency in triple-negative breast cancer.
NPJ Breast Cancer 10: 2024 60
1